全身及部位特异性[18F]FDG摄取模式在PET/CT上鉴别风湿性多肌痛与其他炎症性疾病的价值有限:两个未经治疗疑似风湿性多肌痛队列
研究前瞻性纳入丹麦和荷兰两个队列的未经治疗疑似风湿性多肌痛(PMR)患者,分别含66/27例和36/21例PMR/非PMR患者,评估34个解剖部位的[18F]FDG摄取模式。PMR患者在某些部位双侧摄取≥肝脏的比例高于非PMR患者,但亚组分析显示部分非PMR患者呈现相似全身模式,且部位特异性摄取模式在两组间相似。结论认为评估全身或部位特异性[18F]FDG摄取模式不能提高鉴别PMR与其他炎症性疾病的诊断准确性,[18F]FDG-PET/CT应主要用于排除PMR的临床诊断。
要点
- PMR患者坐骨结节、肩关节、髋关节及腰椎棘突双侧[18F]FDG摄取≥肝脏的比例高于非PMR患者。
- 亚组分析显示部分非PMR炎症性疾病患者呈现与PMR相似的全身[18F]FDG摄取模式。
- 部位特异性[18F]FDG摄取模式在PMR与非PMR患者间相似,不能提高鉴别诊断准确性。
核心结论
- 评估全身或部位特异性[18F]FDG摄取模式不能提高鉴别PMR与其他炎症性疾病的诊断准确性。
- [18F]FDG-PET/CT应主要用于排除PMR的临床诊断。
研究设计与样本
- 前瞻性纳入丹麦和荷兰两个独立队列的未经治疗疑似PMR患者,分别含66/27例和36/21例PMR/非PMR患者。
- 所有患者治疗前接受[18F]FDG-PET/CT扫描,评估34个不同解剖部位的[18F]FDG摄取。
- 根据形状对每个解剖部位内的部位特异性[18F]FDG摄取模式进行分类。
主要发现
- PMR患者较非PMR患者更常见双侧[18F]FDG摄取≥肝脏:坐骨结节91% vs 41%,肩关节86% vs 45%,髋关节83% vs 52%,腰椎棘突70% vs 30%。
- 亚组分析比较非PMR其他炎症性疾病患者与PMR患者,显示若干非PMR患者呈现相似的全身[18F]FDG摄取模式。
- 部位特异性[18F]FDG摄取模式在PMR与非PMR患者中相似。
临床怎么用
- 作者结论认为[18F]FDG-PET/CT应主要用于排除PMR的临床诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been hypothesized that 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography (PET) computed tomography (CT) can distinguish polymyalgia rheumatica (PMR) from non-PMR patients based on the [18F]FDG-uptake patterns. Nevertheless, a comprehensive assessment of whole-body [18F]FDG-patterns across all uptaking musculoskeletal sites, as well as site-specific [18F]FDG-uptake patterns, has not been conducted. Therefore, this study aimed to investigate both the overall whole-body [18F]FDG-uptake patterns and the specific uptake patterns at individual sites in patients suspected of having PMR. METHODS: Two distinct cohorts of patients with suspected PMR from Denmark and the Netherlands were prospectively included, encompassing 66/27 and 36/21 PMR/non-PMR patients, respectively. The cohorts consisted of treatment-naïve patients, who underwent pre-treatment [18F]FDG-PET/CT scans. The [18F]FDG-uptake was then assessed across 34 different anatomical sites. Furthermore, the site-specific [18F]FDG-uptake pattern within each anatomical site was categorized according to its shape. RESULTS: Patients with PMR were more likely than non-PMR patients to have bilateral [18F]FDG-uptake equal to or above liver compared at the ischial tuberosities (91%/41%), shoulder joints (86%/45%), hip joints (83%/52%), and along the lumbar spinal processes (70%/30%). However, a subgroup analysis comparing non-PMR patients with other inflammatory conditions to patients with PMR revealed that several non-PMR patients exhibited a similar whole-body [18F]FDG-uptake pattern. Furthermore, site-specific [18F]FDG-uptake patterns were similar in patients with PMR and non-PMR. CONCLUSION: Assessing whole-body or site-specific [18F]FDG-uptake patterns does not improve the diagnostic accuracy in distinguishing PMR from other inflammatory diseases. Consequently, [18F]FDG-PET/CT should mainly be used to rule out a clinical diagnosis of PMR. TRIAL REGISTRATION: ClinicalTrials.gov (NCT04519580). Registered 17th of August 2020.
引用
- Nielsen AW, van Praagh GD, van der Geest KSM, et al. Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica. EJNMMI Res. 2025. PMID: 40307615. doi:10.1186/s13550-025-01233-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。